Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Yuki

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
American Journal of Respiratory and Critical Care Medicine|April 14, 2000
The relationship between chronic hypoxemia and activation of the tumor necrosis factor-alpha system in patients with chronic obstructive pulmonary diseaseN Takabatake, H Nakamura, S Abe, et al.
American Journal of Respiratory and Critical Care Medicine|April 1, 1997
Elevated levels of cytokeratin 19 in the bronchoalveolar lavage fluid of patients with chronic airway inflammatory diseases--a specific marker for bronchial epithelial injuryH Nakamura, S Abe, Y Shibata, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1991
Serotonin (5-HT)3 receptor blocking activities of YM060, a novel 4,5,6,7-tetrahydrobenzimidazole derivative, and its enantiomer in anesthetized ratsK Miyata, T Kamato, M Yamano, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1994
YM022 [(R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo-5-phenyl- 1H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea], a potent and selective gastrin/cholecystokinin-B receptor antagonist, prevents gastric and duodenal lesions in ratsA Nishida, Y Takinami, H Yuki, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1991
Pharmacologic profile of (R)-5-[(1-methyl-3-indolyl)carbonyl]-4,5,6,7-tetrahydro-1H- benzimidazole hydrochloride (YM060), a potent and selective 5-hydroxytryptamine3 receptor antagonist, and its enantiomer in the isolated tissueK Miyata, T Kamato, A Nishida, et al.
Alimentary Pharmacology & Therapeutics|February 1, 1997
YF476 is a new potent and selective gastrin/cholecystokinin-B receptor antagonist in vitro and in vivoY Takinami, H Yuki, A Nishida, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1994
Pharmacological profile of (R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo- 5-phenyl-1H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea (YM022), a new potent and selective gastrin/cholecystokinin-B receptor antagonist, in vitro and in vivoA Nishida, K Miyata, R Tsutsumi, et al.
The American Journal of Physiology|November 1, 1995
Gastrin receptor antagonist YM022 prevents hypersecretion after long-term acid suppressionA Nishida, A Kobayashi-Uchida, S Akuzawa, et al.
Arzneimittel-Forschung|June 3, 1998
Effects of YF476, a potent and selective gastrin/cholecystokinin-B receptor antagonist, on gastric acid secretion in beagle dogs with gastric fistulaY Takemoto, H Yuki, A Nishida, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|August 16, 2006
Target preparation by the precipitation method for nuclear reactionsK Takamiya, T Ohtsuki, H Yuki, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
American Journal of Respiratory and Critical Care Medicine|April 14, 2000
The relationship between chronic hypoxemia and activation of the tumor necrosis factor-alpha system in patients with chronic obstructive pulmonary diseaseN Takabatake, H Nakamura, S Abe, et al.
American Journal of Respiratory and Critical Care Medicine|April 1, 1997
Elevated levels of cytokeratin 19 in the bronchoalveolar lavage fluid of patients with chronic airway inflammatory diseases--a specific marker for bronchial epithelial injuryH Nakamura, S Abe, Y Shibata, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1991
Serotonin (5-HT)3 receptor blocking activities of YM060, a novel 4,5,6,7-tetrahydrobenzimidazole derivative, and its enantiomer in anesthetized ratsK Miyata, T Kamato, M Yamano, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1994
YM022 [(R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo-5-phenyl- 1H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea], a potent and selective gastrin/cholecystokinin-B receptor antagonist, prevents gastric and duodenal lesions in ratsA Nishida, Y Takinami, H Yuki, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1991
Pharmacologic profile of (R)-5-[(1-methyl-3-indolyl)carbonyl]-4,5,6,7-tetrahydro-1H- benzimidazole hydrochloride (YM060), a potent and selective 5-hydroxytryptamine3 receptor antagonist, and its enantiomer in the isolated tissueK Miyata, T Kamato, A Nishida, et al.
Alimentary Pharmacology & Therapeutics|February 1, 1997
YF476 is a new potent and selective gastrin/cholecystokinin-B receptor antagonist in vitro and in vivoY Takinami, H Yuki, A Nishida, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1994
Pharmacological profile of (R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo- 5-phenyl-1H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea (YM022), a new potent and selective gastrin/cholecystokinin-B receptor antagonist, in vitro and in vivoA Nishida, K Miyata, R Tsutsumi, et al.
The American Journal of Physiology|November 1, 1995
Gastrin receptor antagonist YM022 prevents hypersecretion after long-term acid suppressionA Nishida, A Kobayashi-Uchida, S Akuzawa, et al.
Arzneimittel-Forschung|June 3, 1998
Effects of YF476, a potent and selective gastrin/cholecystokinin-B receptor antagonist, on gastric acid secretion in beagle dogs with gastric fistulaY Takemoto, H Yuki, A Nishida, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|August 16, 2006
Target preparation by the precipitation method for nuclear reactionsK Takamiya, T Ohtsuki, H Yuki, et al.
Pageof 6